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Abstract
Background: Gold compounds have shown promise in the treatment of non-communicable diseases such as
rheumatoid arthritis and cancer, and are considered of value as anti-microbial agents against Gram-negative and
Gram-positive bacteria, and have anti-parasitic properties against Schistosoma mansoni, Trypanosoma brucei,
Plasmodium falciparum, Leishmania infantinum, Giardia lamblia, and Entamoeba histolytica. They are known to affect
enzymatic activities that are required for the cellular respiration processes.
Methods: Anti-amoebic effects of phosphanegold(I) thiolates were tested against clinical isolate of A. castellanii
belonging to the T4 genotype by employing viability assays, growth inhibition assays, encystation assays,
excystation assays, and zymographic assays.
Results: The treatment of A. castellanii with the phosphanegold(I) thiolates tested (i) had no effect on the viability
of A. castellanii as determined by Trypan blue exclusion test, (ii) did not affect amoebae growth using PYG growth
medium, (iii) did not inhibit cellular differentiation, and (iv) had no effect on the extracellular proteolytic activities of
A. castellanii.
Conclusion: Being free-living amoeba, A. castellanii is a versatile respirator and possesses respiratory mechanisms
that adapt to various aerobic and anaerobic environments to avoid toxic threats and adverse conditions. For the
first time, our findings showed that A. castellanii exhibits resistance to the toxic effects of gold compounds and
could prove to be an attractive model to study mechanisms of metal resistance in eukaryotic cells.
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Background
Acanthamoeba is a free living pathogenic protist that
can cause cutaneous lesions, a vision-threatening kera-
titis, and a rare but fatal infection of the brain, identified
as granulomatous amoebic encephalitis [1–4]. Acanth-
amoeba keratitis infection is of explicit concern given
the rise in the number of wearers of contact lenses
worldwide, a population susceptible to this infection.
Treatment involves hourly topical application of a
mixture of drugs comprising of polyhexamethylene
biguanide or chlorhexidine digluconate together with
propamidine isethionate or hexamidine. Moreover,
chloramphenicol or neomycin is also given to prevent
mixed bacterial infection [5]. Treatment lasts for several
months [5, 6]. Furthermore, the treatment is problematic
and cumbersome, in part due to the ability of this facul-
tative parasite to go through phenotypic interchanging
into a double-walled cyst form, which is impervious to
many anti-microbial drugs and harsh conditions, and an
active vegetative trophozoite stage that is more vulner-
able to anti-microbials, often leading to recurrence of in-
fection [7–9]. Consequently, there is a crucial need to
develop anti-microbials targeting both the cyst stage and
the trophozoite stage of Acanthamoeba.
Gold compounds have been well recognised for their
putative properties and potential medical applications
[10, 11]. For example, the assessment of the potential
anti-cancer activity and the determination of signalling
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pathways for apoptosis of phosphane gold(I) carboni-
midothioates, Ph3PAu[SC(OR) = NPh], R =Me, Et and
iPr, and related species have been carried out recently
[12–14], see Fig. 1 for chemical structures. Moreover,
closely related compounds have shown potential as
anti-microbial agents against Gram-positive bacteria
[15]. Gold(I) compounds have potential medical appli-
cations and shown to possess anti-tumour activities
[16, 17], anti-parasitic [18] and anti-microbial activ-
ities [19–21] via a variety of mechanisms including
respiration. In this study, for the first time, we deter-
mined the effects of phosphanegold(I) thiolates,
AAu1–AAu3, Fig. 1, on a keratitis-causing isolate of
A. castellanii belonging to the T4 genotype. Further-




All chemicals were purchased from Sigma Labs (Poole,
Dorset, England), unless otherwise stated. The phospha-
negold(I) thiolates, AAu1–AAu3, were prepared and
characterised using methodology as previously described
[14]. The molecular structures and weights of AAu1–
AAu3 are given in Fig. 1. A stock solution (10 mM) was
prepared and stored at −20 °C until used. Control cul-
tures contained the same volume of respective solvents.
Cultures of A. castellanii
A. castellanii belonging to the T4 genotype (ATCC
50492) is a clinical isolate that was initially isolated from
a keratitis patient and grown in 75 cm2 tissue culture
flasks in 10 mL at a cell density of 5×105 cells per mL in
PYG medium [proteose peptone 0.75% (w/v), yeast ex-
tract 0.75% (w/v) and glucose 1.5% (w/v)] without
shaking at 30 °C as described previously [22, 23]. At this
cell density, parasites reach confluency within 48 h. Ac-
tive trophozoites are attached to the bottom of the flasks
while any dormant cells are non-adherent in the super-
natant. To obtain trophozoites, supernatant was aspi-
rated and 10 mL of RPMI-1640 was added. Next, flasks
were placed on ice for 20 min to detach bound amoebae
followed by gentle tapping and observed under the
inverted microscope to ensure amoebae detachment had
occurred. Finally, the parasites were collected in 50 mL
tubes, followed by centrifugation at 1500×g for 5 min,
resuspended in one mL of RPMI-1640 and used in
experiments.
Amoebicidal assays
To determine amoebicidal activity of AAu1–AAu3, A.
castellanii trophozoites (5 × 105 amoebae/0.5 mL/well)
were incubated in RPMI-1640 with various concentra-
tions of AAu1–AAu3 in 24-well plates as described pre-
viously [20–24]. Plates were incubated at 37 °C for 24 h.
Following this incubation, amoebae viability was deter-
mined by adding 0.1% Trypan blue and number of live
(non-stained) and dead (stained) A. castellanii were enu-
merated using a haemocytometer. The counts from A.
castellanii incubated with RPMI-1640 alone, and the
solvent alone (chloroform) were used as controls. Data
are represented as the mean ± standard error of at least
three independent experiments. To determine whether
the effects of AAu1–AAu3 are irreversible, A. castellanii,
5 × 105 trophozoites, were incubated with AAu1–AAu3
for 24 h as described above. After this incubation, amoe-
bae were centrifuged for 10 min at 1,000xg and super-
natant was aspirated, followed by the addition of 0.5 mL
of RPMI-1640. This process was repeated 3X to remove
extracellular AAu1–AAu3. Finally, A. castellanii were
re-suspended in PYG as a food source and inoculated in
24-well plates. Plates were incubated at 37 °C for up to
72 h and re-emergence of trophozoites was considered
as viable amoebae, and absence of trophozoites was con-
sidered as non-viable amoebae. In some experiments,
plates were incubated for up to a week to observe the
emergence of viable trophozoites.
Amoebistatic assays
To determine the effects of AAu1–AAu3 on the growth
of A. castellanii, assays were performed by exposing 5 ×
105 trophozoites to different concentrations of AAu1–
AAu3 in growth medium, i.e., PYG in 24-well plates.
Next, the plates were incubated at 30 °C for 48 h.
For controls, 5 × 105 trophozoites were inoculated in
100% PYG medium, 100% non-nutritive PBS and
respective amounts of solvents plus PYG medium
and incubated in the above-mentioned conditions.
After this incubation, the number of amoebae was
Fig. 1 Chemical diagrams, abbreviations and molecular weights
for AAu1–AAu3
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determined by haemocytometer counting. All experiments
were performed at least three times in duplicate.
Preparation of A. castellanii cysts and excystation assays
To prepare A. castellanii cysts, encystation was induced
by inoculating 5 × 106 A. castellanii trophozoites onto
non-nutrient agar plates [prepared using 3% (w/v) bac-
teriological agar] and incubating at 30 °C for up to
14 days [25]. Food deprivation resulted in trophozoite
transformation into the cyst form. Next, 10 mL of PBS
was added to each plate. Cysts were then gently scraped
off the agar surface using a cell scraper. PBS containing
cysts was collected in 15 mL tube and centrifuged at
3000 × g for 10 min to pellet cysts. The supernatant was
aspirated and cysts resuspended in RPMI-1640, enumer-
ated using a haemocytometer and used in experiments.
To determine the effects of AAu1–AAu3 on excystation,
assays were performed by inoculating A. castellanii cysts
(5 × 104 cysts per mL PYG per well of 24-well plates) in
the presence or absence of different concentrations of
AAu1–AAu3. Plates were incubated at 30 °C and ob-
served every 24 h under the inverted microscope for the
emergence of viable trophozoites for up to 72 h.
Encystation assays
Encystation assays were performed as described previ-
ously [25]. Briefly, 2 × 106 amoebae were incubated in
0.5 mL of PBS containing 50 mM MgCl2 and 10% glu-
cose (i.e., encystation trigger) per well of 24-well plates.
The plates were incubated at 30 °C for 72 h without
shaking. After this incubation, amoebae viability was
quantified using a haemocytometer via Trypan blue ex-
clusion assay. Next, SDS (0.5% final conc.) was added for
10 min. At this concentration, SDS solubilizes amoebae
trophozoites but not cysts. Finally cysts were enumerated
using a haemocytometer and used in experiments. To de-
termine the effects of AAu1–AAu3 on encystation, assays
were performed in the presence of different concentra-
tions of drugs. Briefly 2 × 106 amoebae were incubated in
PBS with various concentrations of drugs and incubated
at room temperature for 20 min. Following this, 50 mM
MgCl2 and 10% glucose was added as a trigger for encyst-
ation and plates were incubated at 30 °C for 72 h. Finally,
parasites counts were determined using a haemocytom-
eter. Amoebae incubated without inhibitors and encyst-
ation trigger were used as controls. The respective
amounts of solvents were used as solvent controls.
Zymographic assays
The extracellular proteolytic activities of Acanthamoeba
were determined using zymographic assays as previously
described [26]. Briefly, A. castellanii were incubated in the
presence or absence of various concentrations of AAu1–
AAu3 for 24 h. Next day, cell-free supernatants (CM,
conditioned medium) were collected by centrifugation.
The CM were electrophoresed on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) containing
gelatin (2 mg/mL) as a protease substrate as previously de-
scribed [26]. Following electrophoresis, gels were washed
in 2.5% Triton X-100 (w/v) for 60 min, then incubated in
developing buffer (50 mM Tris–HCl, pH 7.5, containing
10 mM CaCl2) at 37 °C overnight. Next day, gels were
stained with Coomassie Brilliant Blue. Areas of gelatin di-
gestion were visualised as non-staining regions in the gel.
Statistical analysis
Statistical significance for differences was evaluated
using 2 sample t-test; two-tailed distribution, comparing
the mean of two independent groups in Excel. A critical
value of P < 0.05 was used for all analysis. For graphical
representation of the data, y-axis error basis indicate the
standard error of the data for each point on the figure.
Results
Phosphanegold(I) thiolates, AAu1–AAu3, did not affect A.
castellanii trophozoites viability
To ascertain the effects of AAu1–AAu3, amoebicidal as-
says were performed as stated in Materials and Methods.
The results revealed that AAu1–AAu3 did not exhibit
anti-amoebic effects against A. castellanii trophozoites
(Fig. 2a and b). In the presence of 100, 200 and 300 μM
AAu1, the number of viable amoebae was 3.41 × 105 ±
1.12 × 104, 2.84 × 105 ± 5.51 × 103 and 2.62 × 105 ± 3.47 ×
104, respectively. However, this was not significant when
compared to the respective solvent controls (5, 10 and
15 μL chloroform). Likewise, for 100, 200 and 300 μM
AAu2, the number of viable amoebae was 2.88 × 105 ±
1.75 × 104, 2.72 × 105 ± 4.73 × 104 and 2.30 × 105 ± 2.14 ×
104, respectively. For 100, 200 and 300 μM AAu3, the
number of viable amoebae was 2.94 × 105 ± 1.56 × 104,
2.76 × 105 ± 3.09 × 104 and 2.23 × 105 ± 3.39 × 104, re-
spectively (Fig. 2a). Overall, the results showed no effects
of AAu1–AAu3 on amoebae viability.
Phosphanegold(I) thiolates, AAu1–AAu3, did not exhibit
amoebistatic effects against A. castellanii trophozoites
Amoebistatic assays were performed in the presence or
absence of AAu1–AAu3. When incubated in 100% growth
medium, the number of amoebae increased from 5 × 105
to 8.78 × 105 ± 3.21 × 104 (Fig. 3). In contrast, amoebae in-
cubated in non-nutritive RPMI medium had no growth
stimulatory effect but exhibited reduced number of amoe-
bae i.e., the amoebae count decreased from 5 × 105 to
3.29 × 105 ± 6.63 × 104 (Fig. 3). For AAu1–AAu3, the re-
sults revealed that there were no amoebistatic effects
against A. castellanii even at 300 μM concentrations. For
AAu1–AAu3, the number of amoebae increased from 5 ×
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105 to 9.56 × 105 ± 8.42 × 104, 7.02 × 105 ± 9.38 × 104 and
9.85 × 105 ± 3.07 × 104, respectively at 300 μM.
Phosphanegold(I) thiolates, AAu1–AAu3, did not affect
excystation in A. castellanii
When incubated in growth medium, the number of
amoebae increased from 5 × 104 to 3.91 × 105 ± 1.63 ×
104 as compared to 5 × 104 to 1.24 × 105 ± 1.38 × 104 in
RPMI medium, which is a non-nutritive medium
(Fig. 4a). However, for AAu1–AAu3, the number of
amoebae increased from 5 × 104 to 3.50 × 105 ± 1.63 ×
104, 3.73 × 105 ± 2.50 × 104 and 3.21 × 105 ± 2.81 × 104,
respectively at 300 μM (Fig. 4a). Nonetheless, this was
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Fig. 2 a The effects of AAu1–AAu3 on the viability of A. castellanii belonging to T4 genotype. Briefly A. castellanii (5 × 105 trophozoites) were incubated
with gold thiolates at 37 °C for 24 h. Next day, Trypan blue exclusion assays were performed and amoebae were counted using haemocytometer. Note
that none of the compounds shows significant effect on the viability of A. castellanii as compared to control. The results represent the mean ± standard
error of three different experiments performed in duplicates. b Representative effects of AAu1–AAu3 on survival of A. castellanii. Briefly, A. castellanii (5 ×
105 trophozoites) were incubated with AAu1–AAu3 at 37 °C for 24 h and were counted using a heamocytometer. Next, drugs-treated amoeba were
washed and re-inoculated in fresh PYG at 37 °C for up to 24 h and observed under a microscope. The results are representative of three independent
experiments. B1 is Amoeba alone; B2 is solvent alone (chloroform 15 μL); B3 is AAu1 (300 μM); B4 is AAu2 (300 μM); B5 is AAu3 (300 μM); B6 is
chlorhexidine (300 μM)
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medium control and the results revealed that none of
the compounds tested had any effects on excystation,
and amoebae were able to excyst at rates comparable to
controls (Fig. 4b).
Phosphanegold(I) thiolates, AAu1–AAu3, did not affect
encystation in A. castellanii
To determine the effects of AAu1–AAu3 on A. castella-
nii encystation, assays were performed in the presence
and absence of these compounds. When incubated in
encystation medium, the number of amoebae decreased
from 5 × 105 to 1.73 × 105 ± 2.50 × 103 (Fig. 5). However,
for AAu1–AAu3, the number of amoebae was reduced
from 5 × 105 to 1.18 × 105 ± 4.75 × 104, 1.17 × 105 ±
2.06 × 104 and 1.17 × 105 ± 1.44 × 104, respectively, at
300 μM (Fig. 5). However, this was not significant when
compared to the respective encystation medium control.
The results revealed that none of the trial compounds
tested had any effects on encystation.
Phosphanegold(I) thiolates, AAu1–AAu3, did not effect A.
castellanii extracellular proteolytic activity
To determine the effect of AAu1–AAu3 on the extracel-
lular proteases of A. castellanii, zymographic assays were
performed using gelatin as substrate as described in ma-
terials and methods. In the absence of any trial com-
pound, A. castellanii exhibited proteolytic activities and
a visible band of 140 kDa was observed (Fig. 6). Simi-
larly, both, A. castellanii treated in the presence of dif-
ferent concentrations of AAu1–AAu3 and in RPMI
alone exhibited extracellular proteases at similar levels
(Fig. 6).
Discussion
Gold(I) complexes have potential medical applications
[10, 11]. Thus, gold(I) derivatives have been explored for
anti-tumour activity [16, 17] as well as anti-parasitic [18]
and anti-microbial agents [19–21]. Gold has properties
such as high thermal/chemical stability and resistant to
oxidation, yet is mechanically soft with high electric con-
ductivity enabling its applications in several disciplines
ranging from healthcare to engineering. For example,
gold compounds have been successfully used in the
treatment of rheumatoid arthritis and are shown to slow
down the progression of rheumatic disorder [27, 28].
Many of the biologically active gold(I) compounds con-
tain thiolates and/or phosphane as ligands [10, 11, 16,
17, 21] and inhibit thioredoxin reductase [29, 30]. More
recently, it is shown that the gold(I) compounds exhibit
anti-parasitic activities such as targeting Schistosoma
mansoni [31], Trypanosoma brucei [32], Echinococcus
granulosus [33], Plasmodium falciparum [34], Leish-
mania infantinum [35] Giardia lamblia [36], and Ent-
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Fig. 3 The effects of AAu1–AAu3 on the growth of A. castellanii belonging to T4 genotype. Briefly A. castellanii (5 × 105 trophozoites) were
incubated with AAu1–AAu3 in growth medium, PYG at 37 °C for 24 h. After this period, amoebae were counted using haemocytometer. Note
that none of the trial compounds shows significant effect on the growth of A. castellanii as compared to control. The results represent the mean
± standard error of three different experiments performed in duplicates
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gold(I) compounds target E. histolytica by inhibiting
thioredoxin reductase activity [37]. The anti-bacterial ac-
tivities of gold(I) compounds showed that these com-
pounds affect Clostridium difficile and Treponema
denticola by disrupting the selenium metabolism by tar-
geting selenoproteins required for energy [38, 39], while
Staphylococcus aureus growth is inhibited by gold(I)
compounds [40]. Other studies proposed targets includ-
ing the inhibition of mitochondrial enzymes and of the
proteasome compounds [41, 42] and the inhibition of
the zinc finger protein poly (adenosine diphosphate
(ADP) ribose) polymerase 1 (PARP-1) [43, 44]. Notably,
PARP’s are crucial proteins that are important in drug
resistance in cancer as they play an essential role in
DNA repair by detecting DNA strand breaks and cata-
lyzing poly (ADP-ribosylation) [45]. Other biological tar-
gets of gold(I) compounds with prokaryotic and
eukaryotic cells are yet to be discovered.
Based on these findings, it was logical to test the anti-
amoebic effects of phosphanegold(I) thiolates, AAu1–
AAu3, on the biological properties of A. castellanii be-
longing to the T4 genotype. The results revealed that
AAu1–AAu3 did not show any effects on the biological
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Fig. 4 a The effects of AAu1–AAu3 on excystation of A. castellanii belonging to T4 genotype. Briefly A. castellanii (5 × 104 cyst) were incubated
with AAu1–AAu3 in growth medium, PYG at 37 °C for 48 h. After this period, amoebae were counted using a haeamocytometer. Note that
AAu1–AAu3 were unable to inhibit excystation. The dotted line represents the original inoculum. The results represent the mean ± standard error
of two different experiments performed in duplicates. b Representative effects of AAu1–AAu3 on excystation of A. castellanii. The results are
representative of three independent experiments. B1 is Amoeba alone; B2 is solvent alone (chloroform 15 μL); B3 is AAu1 (300 μM); B4 is AAu2
(300 μM); B5 is AAu3 300 (μM)
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performing (i) viability assays using Trypan blue exclu-
sion test, (ii) amoebae growth using PYG growth
medium, (iii) cellular differentiation using encystation
and excystation assays and (iv) enzymatic activities by
determining extracellular proteases profiles. The re-
ported results are highly reproducible and consistently
showed that AAu1–AAu3 do not affect the biological
properties of A. castellanii. There could be several
explanations for the findings observed in this study. For
example, the mode of action of gold requires it to enter
the cell, via the hydrophobic cell membrane, to produce
damage, most likely through transmembrane proteins
that may be different in A. castellanii. Notably, gold(I)
compounds are well known to affect enzymatic activities
that are required for the cellular respiration processes.
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Fig. 5 The effects of AAu1–AAu3 on encystation of A. castellanii belonging to T4 genotype. Briefly, 5 × 105 trophozoites were incubated with
AAu1–AAu3 in encystation medium (50 mM MgCl2 and 10% glucose) as described in “Methods”. The dotted line represents the original
inoculum. The results are expressed as the mean ± standard error of three independent experiments performed in duplicate
AAu3 AAu2 AAu1 
140 kDa
Amoeba 
alone 100µM 200µM 300µM 100µM 100µM 200µM200µM 300µM 300µM
Fig. 6 The effects of AAu1–AAu3 on extracellular proteolytic activity of A. castellanii belonging to T4 genotype. Zymographic assays were
performed using gelatin as a substrate to determine the effects of AAu1–AAu3 on extracellular proteases of A. castellanii using 100, 200 and
300 μM concentrations. The results revealed that none of AAu1–AAu3 inhibited A. castellanii proteases when compared with amoeba in RPMI
alone. The results are representative of three independent experiments
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habitat of Acanthamoeba is the environment with di-
verse respiratory mechanisms and wide exposure to
metals, thus Acanthamoeba is likely to possesses mecha-
nisms to inhibit the toxic effects exerted by metals. A.
castellanii is well known as a versatile respirator and
possesses several mitochondria per cell and respiratory
mechanisms that adapt to various aerobic and anaerobic
environments to dodge toxic threat and adverse condi-
tions. It is possible that the toxic effects of metals are
compensated by switching the type of respiration or the
use of an efflux system to rid toxic metals. Future stud-
ies are needed to test higher concentration of phospha-
negold(I) thiolates compounds and/or in combining
phosphanegold(I) thiolates with current anti-amoeba
drugs, such as chlorhexidine to determine their im-
proved efficacy against pathogenic Acanthamoeba. Over-
all, these findings suggest that Acanthamoeba exhibits
resistance to toxic effects of gold(I) compounds and
could prove to be an attractive model to study mecha-
nisms of metal resistance in eukaryotic cells.
Conclusions
Although gold compounds have shown promise in the
treatment of non-communicable diseases such as
rheumatoid arthritis, anti-tumour activities, as well
as antibacterial properties, and anti-parasitic properties
against protozoan pathogens, T. brucei, P. falciparum, L.
infantinum, G. lamblia, and E. histolytica, often by tar-
geting respiration pathways, our studies demonstrated
that A. castellanii exhibited resistance against their toxic
effects. The gold derivatives tested had no effect on the
viability of A. castellanii, did not inhibit amoebae
growth, or cellular differentiation processes or extracel-
lular proteolytic activities. As Acanthamoeba is a versa-
tile respirator, it can adapt to various aerobic and
anaerobic environments to avoid toxic threats. Our stud-
ies suggest that Acanthamoeba could prove to be a use-
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